1. Home
  2. GP vs BIVI Comparison

GP vs BIVI Comparison

Compare GP & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GreenPower Motor Company Inc.

GP

GreenPower Motor Company Inc.

HOLD

Current Price

$0.83

Market Cap

9.4M

ML Signal

HOLD

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$1.20

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GP
BIVI
Founded
2010
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
10.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GP
BIVI
Price
$0.83
$1.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.6K
74.6K
Earning Date
02-13-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,542,318.00
N/A
Revenue This Year
$81.12
N/A
Revenue Next Year
$91.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$1.16
52 Week High
$10.90
$25.76

Technical Indicators

Market Signals
Indicator
GP
BIVI
Relative Strength Index (RSI) 27.58 27.36
Support Level $0.76 $1.40
Resistance Level $0.86 $1.46
Average True Range (ATR) 0.07 0.09
MACD 0.03 -0.02
Stochastic Oscillator 21.43 9.47

Price Performance

Historical Comparison
GP
BIVI

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: